Remyelination in the adult CNS depends on activation, differentiation, and functional integration of resident oligodendroglial precursor cells (OPCs) and constitutes the only spontaneous neuroregenerative process able to compensate for functional deficits upon loss of oligodendrocytes and myelin sheaths as it is observed in multiple sclerosis. The proteins encoded by p57kip2-and by human endogenous retrovirus type W (pHERV-W) envelope genes were previously identified as negative regulators of OPC maturation. We here focused on the activity of the ENV protein and investigated how it can be neutralized for an improved myelin repair. We could demonstrate that myelination in vitro is severely affected by this protein but that application of an anti-ENV neutralizing antibody, currently investigated in clinical trials, can rescue the generation of internodes. We then compared p57kip2 and ENV dependent inhibitory mechanisms and found that a dominant negative version of the p57kip2 protein can equally save OPCs (Franklin & Ffrench-Constant, 2017) . However, the overall remyelination capacity remains inefficient and further diminishes over time and disease progression, which can be attributed to limited windows of opportunity (Kotter, Stadelmann, & Hartung, 2011 ) and the presence of extrinsic and intrinsic inhibitors of OPC Peter Göttle and Moritz Förster contributed equally to this study.
| BACKGROUND
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) primarily featuring loss of oligodendrocytes and myelin sheaths. As a consequence of demyelination, axonal functionality is impaired and axons become vulnerable to axonal degeneration, which eventually leads to permanent clinical disabilities. Therefore, apart from addressing the regulation of autoimmune activities in MS, much attention has been paid on endogenous repair processes able to restore myelin sheaths. Myelin repair can be achieved via activation, recruitment and differentiation of resident oligodendroglial precursor cells (OPCs) of the adult central nervous system (CNS) which can differentiate into mature oligodendrocytes and remyelinate demyelinated axons (Franklin & Ffrench-Constant, 2017) . However, the overall remyelination capacity remains inefficient and further diminishes over time and disease progression, which can be attributed to limited windows of opportunity (Kotter, Stadelmann, & Hartung, 2011 ) and the presence of extrinsic and intrinsic inhibitors of OPC Peter Göttle and Moritz Förster contributed equally to this study. differentiation (Kremer, Aktas, Hartung, & Küry, 2011) . It is therefore of considerable interest to provide mechanistic insights and to investigate means for neutralization of oligodendroglial differentiation inhibitors given that myelin repair and neuroregeneration still represent unmet clinical needs. In this regard, a number of trophic and inhibitory processes are currently investigated with only few of them have emerged up to clinical examination (Kremer, Göttle, Hartung, & Küry, 2016; Küry et al., 2018) .
We previously demonstrated that the p57kip2 gene and the human endogenous retrovirus type W (HERV-W) envelope (env) gene encode proteins, which interfere with oligodendroglial differentiation Kremer et al., 2009 Kremer et al., , 2013 . p57kip2 represents an intrinsic inhibitory protein the activity of which was found to depend on tight regulation of its intracellular localization and on direct interactions with binding proteins thereby controlling their site of action or activity . HERV-W, on the other hand, is a multicopy family of evolutionary acquired retroviral elements and revealed to comprise a pathogenic component specifically activated in MS and in a few other autoimmune diseases (first named MSRV, from MS associated RetroViral element). Numerous studies revealed that the MSRV-encoded envelope protein (MSRV-ENV, now referred to as pHERV-W ENV) exerts a profound impact on immune-, endothelial-, and oligodendroglial cells thereby contributing to MS pathogenesis at different levels . As we could demonstrate that the ENV protein either presented on microglial/macrophage cell surfaces or deposited in the extracellular space can activate the Toll-like receptor 4 (TLR4) pathway in OPCs which leads to nitrosative stress and diminished myelin protein production (Kremer et al., 2013) , this process is suspected to impact myelin repair in MS. Of note, a bioactive hyaluronan fragment was recently shown to act via non-canonical TLR4/TRIF signaling in reducing OPC differentiation (Srivastava et al., 2018) , thereby confirming the involvement of this signaling cascade in reducing myelin repair.
Neutralization of the ENV/TLR4 dependent blockade of oligodendroglial cell differentiation represents, therefore, a promising strategy to establish novel and powerful therapeutic approaches. Ex vivo this could successfully be demonstrated by application of the specific neutralizing antibody GNbAC1 (Kremer et al., 2015) , which is currently investigated in MS clinical trials (Curtin et al., 2012; ClinicalTrials.gov Identifier: NCT02782858).
We here addressed to what degree this human-specific pathogenic element can also influence the establishment of myelin sheaths and whether previously identified molecular ways to support and promote oligodendrogenesis by means of modulating the p57kip2 pathway can also protect OPCs from the pHERV-W ENV impact. We found that internode formation can be rescued by the GNbAC1 antibody or by molecular steering of the subcellular localization of the p57kip2 protein via mutation of the putative nuclear localization sequence (NLS) into OPCs according to . Moreover, with ATP6v1d we identified another p57kip2 binding protein, which, as part of the vascular ATPase, is functionally involved in the ENV mediated blockade of OPC maturation. Therefore, our study uncovers parts of the underlying mode of action and demonstrates that both inhibitory pathways show a certain degree of overlap. Moreover, the regulatory mechanism described here might also be of interest in terms of biomedical translation as we present three different ways to counteract the pHERV-W ENV triggered pathway. As neuroregeneration and myelin repair can still not be addressed clinically our findings could therefore provide important insights for the design of novel therapeutic approaches.
| MATERIALS AND METHODS

| Oligodendroglial cell culture
Generation of primary OPCs from postnatal day zero (P0) cerebral rat cortices (Wistar rats of either sex) was performed as previously described (Göttle et al., 2010) . Anti-A2B5 staining (Merck Millipore, Darmstadt, Germany) revealed that the cultures consisted of 98% oligodendroglial cells (data not shown). OPCs were either kept in proliferation-supporting high-glucose DMEM-based Sato medium (ThermoFisher Scientific, Life Technologies, Darmstadt, Germany), supplemented with 10 ng/ml recombinant human bFGF (PeproTech, Hamburg, Germany) and 10 ng/ml recombinant human PDGF-AA (R&D Systems, Darmstadt, Germany) or differentiation was initiated by Sato medium depleted of growth factors and supplemented with 0.5% fetal calf serum (PAA Laboratories, Cölbe, Germany). Oligodendroglial cells were treated with 100 ng/ml full-length ENV protein in differentiation medium (Kremer et al., 2013) . Recombinant pHERV-W ENV was produced by Protein 'eXpert (Grenoble, France) according to quality control specifications of GeNeuro (Geneva, Switzerland).
Endotoxin levels were below the detection limit (<5EU = ml) as measured by the limulus amebocyte lysate test. ENV inactivation was carried out by exposing recombinant ENV to the neutralizing antibody GNbAC1 (GeNeuro SA, Lyon, France; ClinicalTrials.gov identifiers: NCT01699555; NCT01639300). Control experiments were conducted using recombinant protein buffer preparation [20 mM TrisHCl pH 7.5, 150 mM NaCl, 1.5% SDS, 10 mM DTT] at equal dilutions. antibody-mediated neutralization 100 μl fetal calf serum was supplied with 6 μl GNbAC1 (60 μg) or antibody buffer and 4 μl (2 μg) recombinant ENV or buffer, followed by incubation at room temperature.
After preincubation, a 1:200 dilution in OPC differentiation medium was performed and the applied to the cells as described in (Kremer et al., 2015) .
| Myelinating co-culture
Dissociated neuron/oligodendrocyte co-cultures were obtained from embryonic day 16 (E16) rat cerebral cortex (Wistar rats of either sex) according to (Pang et al., 2012) and as previously published by us . Cortical cells were plated on 15-mm poly-D-lysine (0.1 mg/ml) coated coverslips (65,000 cells per coverslip) and kept in myelination medium consisting of N2 and neurobasal medium (ThermoFisher Scientific, Darmstadt, Germany; ratio 1:1) including NGF (50 ng/ml) and NT-3 (10 ng/ml) (both R&D Systems, Minneapolis, MN). The day of primary culture was defined as day one in vitro (DIV1). After 10 days in vitro (DIV10) insulin was excluded and the ratio of the insulin-free N2 to neurobasal medium including B27 supplement (ThermoFisher Scientific, Darmstadt, Germany) was adjusted to 4:1. This myelination medium was further supplemented with 60 ng/ml tri-iodothyronine (T3, Sigma-Aldrich; Taufkirchen, Germany).
Final concentrations of individual N2 medium components (DMEM-F12 based, high glucose; ThermoFisher Scientific, Germany) were insulin (10 μg/ml), transferrin (50 μg/ml), sodium selenite (5.2 ng/ml), hydrocortisone (18 ng/ml), putrescine (16 μg/ml), progesterone (6.3 ng/ml), biotin (10 ng/ml), N-acetyl-L-cysteine (5 μg/ml; all SigmaAldrich, Taufkirchen, Germany), bovine serum albumin (0.1%, Roth, Karlsruhe, Germany), and penicillin-streptomycin (50 U/ml, ThermoFisher Scientific, Darmstadt, Germany). At DIV30, coverslips were washed with PBS, fixed with 4% paraformaldehyde, and processed for immunofluorescent staining. At the onset of myelination DIV17, cultures were treated for another 13 days with myelination medium supplemented with ENV in the presence or absence of GNbAC1 until DIV26 or DIV30. Transplantation of primary transfected OPCs (expression of the p57kip2 NLS mutant protein) onto neuron/oligodendrocyte co-cultures was performed as previously described in details .
| Immunostaining
Fixed cells were permeabilized with PBS containing 0.01% Triton X-100 (Sigma-Aldrich; Taufkirchen, Germany) and unspecific staining was blocked with 10% normal goat serum or donkey serum (SigmaAldrich; Taufkirchen, Germany) for 40 min (Göttle et al., 2010 
| Proximity ligation assay
Direct protein-protein interactions were investigated by means of a proximity ligation assay (PLA; (Soderberg et al., 2006) using Duolink In Situ Red Starter Kit Mouse/Rabbit (Sigma) as previously described by us . Cells were rapidly washed with ice-cold PBS and then fixed at room temperature for 10 min in 4% paraformaldehyde (PFA). Cells were further rinsed 3 × 3 min with PBS containing 0.1% Triton X-100 (Sigma) and then washed 3 × 2 min with 0.05%
Tween 20 in TBS to allow permeabilization. Then one droplet (40 μl)
of Duolink II blocking solution was added to each coverslip and incubated in a preheated humidity chamber for 1 hr at 37 C. Next, the blocking solution was tapped off and cells were incubated for 1 hr at 37 C with primary antibodies anti-TLR4 (1/1000; ab13556, Abcam Cambridge, UK; cat. no. ab13556, RRID:AB_300457), mouse anti-ENV (1/500; GNmAB03 provided by GeNeuro). Duolink anti-rabbit PLUS and anti-mouse MINUS secondary antibodies and Red Detection Reagents were used and antibody incubation, ligation, amplification, and washing steps were performed according to the supplier's manual. Coverslips were then incubated with 50 μg/ml phalloidinfluorescein isothiocyanate (Sigma) for visualization of cells, dried, mounted using Duolink Mounting Media with DAPI, and analyzed using Axiovision 4.2 software (Zeiss) and image processing and analysis in Java software (ImageJ, Wright Cell Imaging Facility).
| Yeast two-hybrid analysis
Yeast two-hybrid screening was performed by Hybrigenics Services, S.A.S. (http://www.hybrigenics-services.com) as previously described . The coding sequence for rat p57kip2/Cdkn1c
(GenBank accession number GI: 76257399) was PCR-amplified and cloned into pB29 as an N-terminal fusion to LexA (N-Cdkn1c-LexA-C). The construct was verified by sequencing the entire insert and used as a bait to screen a random-primed rat hippocampus cDNA library constructed into pP6. pB29 and pP6 derive from the original pBTM116 (Beranger, Aresta, de Gunzburg, & Camonis, 1997; Vojtek & Hollenberg, 1995) and pGADGH (Bartel, 1993) plasmids, respectively.
About 116 × 10 6 clones were screened (12-fold the complexity of the library) using a mating approach with YHGX13 (Y187 ade2-101::loxPkanMX-loxP, matα) and L40ΔGal4 (mata) yeast strains as previously described (Fromont-Racine, Rain, & Legrain, 1997). 63 His+ colonies were selected on a medium lacking tryptophan, leucine, and histidine.
The prey fragments of the positive clones were amplified by PCR and sequenced at their 5 0 and 3 0 junctions. The resulting sequences were used to identify the corresponding interacting proteins in the GenBank database (NCBI) using a fully automated procedure. A confidence score was attributed to each interaction as previously described (Formstecher et al., 2005 ). 
| OPC transfection and assessment of morphology
| Statistical analysis
Data are presented as mean AE standard error of the mean (SEM) and significance was assessed by unpaired two-sided Student's t test and one-way ANOVA followed by Bonferroni`s post hoc comparisons tests according to Scaglione et al. (2018) using GraphPad Prism (RRID: rid_000081). The experimental groups were considered significantly different at *p < .05, **p < .01, ***p < .001. n represents the number of independent experiments.
3 | RESULTS
| GNbAC1-mediated rescue of ENV dependent oligodendroglial myelination deficits
As we found that the negative impact of the ENV protein on oligodendroglial cell differentiation can be successfully neutralized by GNbAC1 (Kremer et al., 2015) , we wanted to investigate whether axonal wrapping and myelination can be equally modulated by ENV and GNbAC1
treatments. To determine a functionally relevant effect of GNbAC1 on the myelin sheath generation, we translated our experiments to myelinating neuron/glia co-cultures according to . Figure 1A) . Upon buffer or GNbAC1 treatment no difference in the extent of cells establishing internodes could be exerted effects on the viability of oligodendrocytes corresponding to our previous findings (Kremer et al., 2015) .
| Alterations in p57kip2 localization upon stimulation with recombinant ENV protein
As nuclear exclusion of the p57kip2 protein revealed to be a crucial process for oligodendroglial maturation, we investigated whether exposure to ENV protein also affects p57kip2 protein subcellular localization. To this end, we studied p57kip2 translocation during spontaneous differentiation of cultured primary oligodendroglial cells upon recombinant ENV protein stimulation. OPC differentiation was induced by means of growth factor withdrawal and accompanied by a decline in the number of cells that accumulate the OPC differentiation inhibitor p57kip2 in the nucleus during the process of differentiation . However, in the presence of ENV protein, nuclear accumulation of p57kip2 protein and thus blocked OPC differentiation was observed (Figure 2 ).
| Rescue of ENV dependent oligodendroglial myelin expression deficits via dominant negative p57kip2
Given that the ENV protein affected the nuclear accumulation of p57kip2 protein and the decreased degree of oligodendroglial maturation, it was of interest to see whether enforced nuclear exclusion of p57kip2 could bypass this negative effect on OPC differentiation. To this end, we modulated the subcellular location of p57kip2 in the presence or absence of ENV by means of nucleofection. OPCs were transfected with an empty control vector (pIRES) or with a construct (p57kip2_NLS) allowing the expression of a dominant negative form of p57kip2 protein exhibiting a mutation within the nuclear localization sequence (NLS), and thus enforcing its cytoplasmic localization . 
| ATP6v1d as novel p57kip2 protein binding partner and vascular-ATPase as effector protein
Considering our previous findings demonstrating that the impact of p57kip2 on oligodendroglial differentiation depends on specific protein/protein interactions, we were wondering whether p57kip2 binding partners could also be mediating protection against pHERV-W ENV. Among the yeast two-hybrid screen identified 63 glial interactions/p57kip2 binding partners , we also detected ATP6v1d, a central component of the vascular ATPase. This ATPase (V-ATPase) is an ATP-driven proton pump present in a variety of cellular membranes. Proton transport, hence, pH homeostasis of intracellular compartments is tightly controlled by this multi-subunit-protein which is crucial for biological processes such as membrane trafficking, protein degradation, receptor mediated-endocytosis, and intracellular trafficking of lysosomal enzymes (Forgac, 2007) . Similar to the already described binding partners Ascl1, Hes5, LIMK-1, and CDK2 , we then investigated whether the subcellular localization of the ATP6v1d protein changed upon either wild-type p57kip2 protein overexpression (p57kip2_wt leading to enforced nuclear accumulation) or overexpression of the p57kip2 NLS mutant protein (p57kip2_NLS; Figure 5 ). Immunofluorescent staining revealed that all primary OPCs expressed ATP6v1d and that it strictly followed the localization pattern of p57kip2 protein such as cytoplasmic accumulation upon overexpression of the dominant negative protein or nuclear localization upon overexpression of wild-type p57kip2. Hence, these observations demonstrate that p57kip2 and ATP6v1d indeed interact physically and also suggest that p57kip2-attributed roles could be exerted by controlling V-ATPase assembly, localization, and function. 
| Blocking vascular ATPase affects TLR4 surface presentation on OPCs
Given the rescue effect of V-ATPase inhibition on the ENV-mediated oligodendroglial cell differentiation blockade, we were wondering whether TLR4 surface presentation could be modulated upon KM91104 treatment (Figure 7a -e). TLR4 surface expression was analyzed after 24 hr of KM91104 treatment by means of laser scanning microscopy. Of note, peak/intensity detection across the cell revealed that the fluorescent peak of TLR4 is shifted towards interior compared to DAPI indicating a dramatic decrease of TLR4 surface expression in OPCs treated with KM91104 as opposed to control.
Subsequent quantification and comparison of TLR4 surface (black bars) versus TLR4 interior expression (white bars) revealed a significant decrease in TLR4 surface expression in presence of ENV and KM91104 as opposed to ENV treatment only (Figure 7a) . In order to further confirm that TLR4 surface localization was altered, we then analyzed the physical interaction between TLR4 and ENV proteins in situ, using a PLA Soderberg et al., 2006) . For this purpose OPCs were stimulated with ENV protein in the absence or presence of KM91104, fixed and subjected to the PLA staining procedure ( Figure 7F -I"). Positive PLA events, reflecting direct TLR4/ENV binding events on the cell surface, resulted in distinct red fluorescent spots and could be observed upon ENV treatment of control cells.
However, no direct TLR4/ENV interaction could be detected in KM91104 treated cells despite the presence of recombinant ENV protein.
3.6 | Rescue of ENV dependent myelination deficits by blocking vascular ATPase 
| DISCUSSION
In this study, we addressed the phenomenon of oligodendroglial differentiation inhibition at the level of OPC's capacity to generate CNS internodes. Using in vitro myelination assays, two of our previously identified inhibitory pathways were examined and found to influence each other. Activation of TLR4 signaling by the pHERV-W ENV protein revealed to be sensitive to expression and subcellular localization of the p57kip2 protein, which was found to directly interact with a VATPase constituent thereby controlling TLR4 surface presentationhence accessibility to ENV. TLR4 signaling as central component of this negative signaling cascade could therefore be confirmed and our previous findings on ENV blocked cell maturation could be extended to sheath generation and axon/glia interactions. Moreover, we present evidence that the ENV mediated differentiation/myelination blockade can be overcome by neutralizing antibodies (GNbAC1), by molecular modulation (p57kip2 localization), or by a small inhibitory molecule (KM91104). Together with our previous description that ENV-affected myelin protein expression is preceded by the induction of oligodendroglial nitrosative stress, which can be prevented by the iNOS inhibitor L-NAME (Kremer et al., 2013) , the arsenal of potential therapeutic agents has therefore been substantially increased.
As we revealed that p57kip2 and pHERV-W ENV dependent inhibitory pathways show at least some degree of overlap and given the numerous inhibitory genes described up to date (Kremer et al., 2011) , the question arises how much negative input oligodendroglial cells receive upon inflammation and disease and whether further connections can be identified. Such functional comparisons will have to be addressed in future experiments, not only for the sake of understanding oligodendroglial biology but also in terms of the identification of suitable targets for pharmacological enhancement of myelin repair (Kremer et al., 2016) .
The high number of pHERV-W-positive MS patients as well as the accumulated high ENV protein load seen in MS histological samples (Kremer et al., 2013; van Horssen, van der Pol, Nijland, Amor, & Perron, 2016) emphasizes the necessity of interfering with this evoked signaling cascade. The anti-ENV monoclonal antibody GNbAC1 is already under clinical examination. On the other hand, genetic modulation of oligodendroglia (such as by modulation of p57kip2 localization) is not a realistic therapeutic option, which is why small inhibitory molecules such as L-NAME and KM91104 may constitute promising starting points. Whether they can be applied alone or in combination, their accessibility to the CNS along with toxicological issues and how to augment oligodendroglial specificity will have to be studied in upcoming in vivo experiments.
V-ATPase-mediated pH-homeostasis of intracellular compartments is required for efficient sorting and trafficking of lipids and proteins in biosynthesis (Al-Bari, 2017) and was previously shown to be linked to TLR4 function, signal transduction and ligand recognition (Cotter, Stransky, McGuire, & Forgac, 2015; Eswarappa, Basu, Joy, & Chakravortty, 2008; Muroi, Takasu, Yamasaki, & Takatsuki, 1993) . Of note, V-ATPase-mediated pH-homeostasis of intracellular compartments is also related to the entry, replication and surface expression of viral envelope glycoproteins and to infection by Ebola-, dengue-, influenza A/C-, and human immunodeficiency viruses as well as to diphtheria-and anthrax toxins uptake (Al-Bari, 2017; Cotter et al., 2015) . Specific V-ATPase inhibition was shown to prevent TLR signaling dependent Salmonella typhimurium virulence (Arpaia et al., 2011) and a reduced TLR4 surface expression was accompanied by inhibited nitric oxide production in murine cells (Eswarappa et al., 2008) , which is in accordance with our previous data showing ENV dependent nitrosative stress induction in oligodendroglial cells (Kremer et al., 2013 (Kremer et al., , 2015 . On the other hand, V-ATPase was also identified as target for the treatment of cancer, osteoporosis, and sepsis (Cotter et al., 2015; Forgac, 2007; Kartner & Manolson, 2014 ) and a contribution of V-ATPase in different white matter pathologies such as the megalencephalic leukoencephalopathy with subcortical cysts (MLC) is suggested based on modulated intracellular pH-homeostasis and protein trafficking in this disease (Brignone et al., 2014) . Of note, an involvement of V-ATPase in white matter homeostasis and brain function is further supported by observations on ATP6ap2. This is yet another constituent of V-ATPase but was also described to act as prorenin receptor and to modulate Wnt signaling (Cruciat et al., 2010) . Moreover, ATP6ap2 mutations have been associated with mental disorders, brain atrophy as well as white matter thinning (Gupta, Vengoechea, Sahaya, & Virmani, 2015) .
Based on our previous studies that demonstrated that protein localization as well as protein-protein interactions can modulate OPC homeostasis and maturation , the finding that enforced cytoplasmic p57kip2 localization and its interaction with the V-ATPase subunit ATP6v1d can overcome the ENV-mediated differentiation blockade is of particular interest. In this regard, functional studies in yeast and the de novo construction of a V-ATPase protein-protein interaction network (V-ATPase interactome) also revealed that activity regulation is primarily dependent on protein-protein interactions (Balakrishna, Manimekalai, & Gruber, 2015; Merkulova et al., 2015) .
The here presented data are still related to examinations ex vivo 
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